SCHEMBL7323451

SCHEMBL7323451

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(OCC(=O)O)cc2)C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.63
ITGB1 P05556 7/20 0.60
ITGA5 P08648 3/20 0.60
ITGB7 P26010 1/20 0.54
ALDH1A1 P00352 1/20 0.54
ITGAV P06756 2/20 0.54
RGS12 O14924 1/20 0.53
KMT2A Q03164 1/20 0.51
FKBP1A P62942 1/20 0.50
ITGA2 P17301 1/20 0.50
MMP1 P03956 1/20 0.49
ADAM17 P78536 1/20 0.49
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
MAPT P10636 1/20 0.47
TSHR P16473 2/20 0.47
MAPK1 P28482 1/20 0.47
HCRTR1 O43613 1/20 0.47
HCRTR2 O43614 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7446444 0.96 ITGA4 (0.61) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7319551 0.94 ITGA4 (0.62) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7325830 0.93 ITGA4 (0.57) ITGA4ITGB1ITGA5ITGB7ITGAV
SCHEMBL7504392 0.92 ITGA4 (0.59) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7319601 0.91 ITGA4 (0.59) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7324887 0.91 ITGA4 (0.59) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL6714623 0.90 ITGA4 (0.66) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL6714379 0.90 ITGA4 (0.60) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL27668499 0.90 ITGB1 (0.63) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL3861626 0.90 ITGB1 (0.63) ITGA4ITGB1ITGA5ITGB7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed